These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10806051)

  • 1. Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.
    Mejjad O; Favre S; Dujardin F; Thomine J; Le Loët X; Weber J
    Osteoarthritis Cartilage; 2000 May; 8(3):230-5. PubMed ID: 10806051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
    Budsberg SC; Johnston SA; Schwarz PD; DeCamp CE; Claxton R
    J Am Vet Med Assoc; 1999 Jan; 214(2):206-10. PubMed ID: 9926009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal gait parameters measured using the Bessou gait analyzer in 79 healthy subjects. Influence of age, stature, and gender. Study Group on Disabilities due to Musculoskeletal Disorders (Groupe de Recherche sur le Handicap de l'Appareil Locomoteur, GRHAL).
    Richard R; Weber J; Mejjad O; Polin D; Dujardin F; Pasquis P; Le Loët X
    Rev Rhum Engl Ed; 1995 Feb; 62(2):105-14. PubMed ID: 7600064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial.
    Williams PI; Hosie J; Scott DL
    Curr Med Res Opin; 1989; 11(7):463-70. PubMed ID: 2528440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
    Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis.
    Chikanza IC; Clarke B; Hopkins R; MacFarlane DG; Bird H; Grahame R
    Br J Clin Pract; 1994; 48(2):67-9. PubMed ID: 8024992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
    Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
    Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentric, randomized, comparative clinical trial to evaluate the efficacy and safety of S-etodolac in the treatment of osteoarthritis in Indian patients.
    Sancheti P; Hardikar M; Karne N; Panse J; Singh S; Maria A; Basu I
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):429-34. PubMed ID: 20557835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinematic and kinetic modifications in walking pattern of hip osteoarthritis patients induced by intra-articular injections of hyaluronic acid.
    Paoloni M; Di Sante L; Dimaggio M; Bernetti A; Mangone M; Di Renzo S; Santilli V
    Clin Biomech (Bristol); 2012 Aug; 27(7):661-5. PubMed ID: 22410192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.
    Dore R; Ballard I; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):656-66. PubMed ID: 8565029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
    Pincus T; Koch GG; Sokka T; Lefkowith J; Wolfe F; Jordan JM; Luta G; Callahan LF; Wang X; Schwartz T; Abramson SB; Caldwell JR; Harrell RA; Kremer JM; Lautzenheiser RL; Markenson JA; Schnitzer TJ; Weaver A; Cummins P; Wilson A; Morant S; Fort J
    Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH; Hsu PN
    Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip.
    Lequesne M; Maheu E; Cadet C; Dreiser RL
    Arthritis Rheum; 2002 Feb; 47(1):50-8. PubMed ID: 11932878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients.
    Mejjad O; Vittecoq O; Pouplin S; Grassin-Delyle L; Weber J; Le Loët X;
    Joint Bone Spine; 2004 Nov; 71(6):542-5. PubMed ID: 15589436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect.
    Maheu E; Mazières B; Valat JP; Loyau G; Le Loët X; Bourgeois P; Grouin JM; Rozenberg S
    Arthritis Rheum; 1998 Jan; 41(1):81-91. PubMed ID: 9433873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
    Pawlotsky Y; Le Dantec P; Jacquelinet C; Lapicque F; Goasguen J; Perdriger A; Veillard E; Guggenbuhl P; Netter P
    Rev Rhum Engl Ed; 1996 Mar; 63(3):179-87. PubMed ID: 8731235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial.
    Detrembleur C; De Nayer J; van den Hecke A
    Osteoarthritis Cartilage; 2005 Mar; 13(3):206-10. PubMed ID: 15727886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
    Andelman SY
    Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.